Kraig Biocraft Laboratories Inc (KBLB): By now, we should be very close to major...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Kraig Biocraft Laboratories Inc (KBLB)

Reply Private New

Keep Last Read

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	61
Posts	16966
Boards Moderated	0
Alias Born	08/26/2011

Re: None

Thursday, 04/17/2025 9:34:54 AM

Thursday, April 17, 2025 9:34:54 AM

By now, we should be very close to major news, the type of news which will truly propel the share price. Production continues, and I honestly believe we are way past the two ton mark. Kim has been releasing phenomenal news every week for many months now increasing the BO price for the company. The floor is now ten dollars for KBLB once milestone news comes out like earnings, contracts, etc.

These are some of the last days to buy KBLB this cheap. And no this is not a pump. These are all facts. GO KBLB!

Keep Last Read

Replies (4) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KBLB News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 09:10:15 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2025 04:15:09 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/29/2025 11:37:15 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:55 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2025 08:44:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2025 09:09:11 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 08:46:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2025 08:30:35 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2025 05:11:50 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/13/2025 10:21:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 10:14:03 PM
Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/19/2024 09:30:04 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/19/2024 09:05:37 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM

More KBLB News

InvestorsHub NewsWire

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow